MID PRICE
98.44
par = 100
YIELD TO MAT.
6.01%
semi-annual
COUPON
5.900%
semi-annual · fixed
MATURITY
2054-09-02
bullet · 28.32y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07
Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAAbout the issuer
Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Modified duration
13.43 y
1bp ↑ ≈ -0.134% P&L
Convexity
277.83
higher = more curvature
Years to maturity
28.32 y
YTM source
Ingested
Market signals · funds disclosing this bond
Subscribe to reveal which signals are holding this bond.Subscribe →
Price history
Sherpa Signal
AS OF 2026-05-07Institutional footprint · signal-level holdings
Interpretation. Moderate institutional footprint, with net accumulation
HOLDERS
15
▲ 4 signals in 7d
AGGREGATE EXPOSURE
$8.1M
USD across all
TOP CONCENTRATION
32.6%
largest holder
FLOW
▲ $186K
▲ 4 signals in 7d
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
100K PAR NOTIONAL · MARKET VALUE
98,440 USD
PRICE
98.44
RFQ routing · coming soon
Security details
VIA OPENFIGICanonical
RPRX 5.9 09/02/54
FIGI
BBG01N5DKSH2
CUSIP
78081BAS2
ISIN
US78081BAS25
Type
Corp
Issued
2024-06-10
Face value
100 USD
Ticker
RPRX 5.9 09/02/54
Sec. type
GLOBAL
Seniority
Senior Unsecured
Issuer curve
RPRX · 10 PTSYield (%) plotted against years-to-maturity. This bond highlighted in amber.
Bonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.
2055-09
6.04%
+3 bps yield+1y duration9 signals in commonSame issuer
2051-09
5.95%
−6 bps yield−3y duration9 signals in commonSame issuer
2050-09
6.00%
−1 bps yield−4y duration10 signals in commonSame issuer
2035-09
5.28%
−73 bps yield−19y duration6 signals in commonSame issuer
2034-09
5.20%
−81 bps yield−20y duration6 signals in commonSame issuer
2031-09
4.79%
−122 bps yield−23y duration6 signals in commonSame issuer